38 /100
MEDIUM RISK
Score updated Jun 11, 2026

AXTI — AXT, Inc. Dilution Risk Tracker

Track AXTI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AXTI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for AXTI.
🔔 Track AXTI — Get forecast alerts →

💹 Market Data

Market Cap$6.75B
Shares Outstanding65.42M
Float48.83M
Cash$107.14M
Debt$68.87M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 69.0% shares (2026Q1 vs prior)
197 institutional holders · 47.31M shares
#1 E20 Capital Ltd 5.11M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 4.56M shares
#3 SUSQUEHANNA INTERNATIONAL GROUP, LLP 3.62M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest8.26M
Days to Cover1.0
% of Float16.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

8-K 8K EVENT Apr 21, 2026
424B5 ATM Apr 20, 2026
4 INSIDER TRANSACTION Mar 16, 2026
4 INSIDER TRANSACTION Mar 16, 2026
4 INSIDER TRANSACTION Mar 16, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track AXTI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AXTI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

🔬 More Research for AXTI
📊 AXTI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 AXTI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.